Vimarsana
Biggest News Aggregation in the World

Page 2 - Vickyb Gregg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vickyb Gregg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vickyb Gregg Today - Breaking & Trending Today

Bahl & Gaynor Inc. Acquires 29,469 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - Vimarsana News

Bahl & Gaynor Inc. Acquires 29,469 Shares of Quest Diagnostics Incorporated (NYSE:DGX)

Bahl & Gaynor Inc. lifted its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 16.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 212,951 shares of the medical research company’s stock after buying an additional 29,469 shares during […]

Motley Fool Asset Management LLC Sells 189 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - Vimarsana News

Motley Fool Asset Management LLC Sells 189 Shares of Quest Diagnostics Incorporated (NYSE:DGX)

Motley Fool Asset Management LLC reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 9.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,822 shares of the medical research company’s stock after selling 189 shares during the quarter. Motley Fool Asset […]

Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Cwm LLC - Vimarsana News

Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Cwm LLC

Cwm LLC increased its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,200 shares of the medical research company’s stock after purchasing an additional 232 shares during the period. […]

Quest Diagnostics (NYSE:DGX) Price Target Raised to $144.00 at Barclays - Vimarsana News

Quest Diagnostics (NYSE:DGX) Price Target Raised to $144.00 at Barclays

Quest Diagnostics (NYSE:DGX – Free Report) had its price objective increased by Barclays from $138.00 to $144.00 in a report released on Thursday morning, Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. Several other brokerages have also issued reports on DGX. StockNews.com raised shares of Quest Diagnostics from […]

Quest Diagnostics (NYSE:DGX) Issues Earnings Results, Beats Expectations By $0.18 EPS - Vimarsana News

Quest Diagnostics (NYSE:DGX) Issues Earnings Results, Beats Expectations By $0.18 EPS

Quest Diagnostics (NYSE:DGX – Get Free Report) issued its quarterly earnings data on Tuesday. The medical research company reported $2.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.86 by $0.18, Briefing.com reports. The business had revenue of $2.37 billion for the quarter, compared to analysts’ expectations of $2.29 billion. Quest […]